A leader of the Pancreatic Cancer Action Network, which aims to double survival rates by 2020, outlines treatment strategies that could lead to success.
JANE DE LARTIGUE, PH.D.
Advertisement
Articles by JANE DE LARTIGUE, PH.D.
In the hopes of recreating the successes achieved in other solid malignancies, researchers have evaluated many types of targeted therapy for the treatment of advanced gastric cancer.
Josh D. Lauring, of Johns Hopkins Medicine, is interested in identifying the genetic changes that drive breast cancer growth in order to determine novel therapeutic targets for drug development and ultimately improve outcomes for patients with breast cancer.
Advertisement
Latest Updated Articles
The Evolving Challenges of Targeting PI3K in Breast CancerPublished: March 13th 2015 | Updated:
Targeting Gastric Cancer: Recent Advances Generate Fresh Hopes After Many FrustrationsPublished: March 13th 2015 | Updated:
- On the Double: Improving Survival Rates in Pancreatic Cancer
Published: March 25th 2018 | Updated:
Advertisement
Advertisement
Trending on CURE
1
SUNRiSE-1 Participant Shares Insights on Bladder Cancer Education
2
Fertility Preservation During Breast Cancer: ‘I Would Do It All Again’
3
Becoming Cancer-Aware: How My Diagnosis Changed the Way My Family Sees Everyday Products
4
What Are My Options for Liver Cancer Treatment?
5
